Advertisement
photo: MW 3DStudio/Shutterstock.com
photo: MW 3DStudio/Shutterstock.com

Retinol is considered to be one of the industry's gold standard ingredients for ageless skin. But how can this wonder-ingredient work even better? Dr Saher Duchi and Dr Danny Goldstein know how it can be shielded with micro encapsula-tion technology.

Retinol is a derivative of vitamin A and is considered to be one of the industry's gold standard ingredients for ageless skin. Reti-nol helps users achieve younger, clearer, and healthier looking skin1,2,3. It does this by increasing cell turnover while enhancing collagen production – a combination that serves to decrease fine lines and wrinkles, unclog pores, combat acne and smooth and refine skin texture. 

Yet whilst Retinol is known for its power-ful results, its efficacy can be easily compromised due to its high sensitivity to oxidation. It degrades in the presence of air, sunlight, acidic conditions, and heavy metals, which ultimately reduces its potency and limits its effectiveness4.

These challenges can be overcome with microencapsulated retinol. By delivering the active ingredient in a stabilised, micro-encapsulated format, the innovative tech-nology helps to improve the performance and shelf life of the final formulation. The polymeric shell ruptures only when the formulation is rubbed into the skin, releas-ing the encapsulated retinol over time. Until this moment, the microcapsule remains unbroken; a condition that serves to main-tain retinol stability and eventually its efficacy. 

figure 1: Representative graph for the mean size and size distribution of the microcapsules.
figure 1: Representative graph for the mean size and size distribution of the microcapsules.

Preparation of microcapsules

The microcapsules loaded with retinol were produced by the solvent extraction method5,6. The microcapsules were pre-pared by dissolving the polymer cellulose acetate butyrate, retinol, and other oil solu-ble additives in ethyl acetate.

The ethyl acetate was mixed with a water phase containing PVA to form an emulsion. The emulsion was then transferred into the extraction water phase. After complete sedimentation of the microcapsules they were collected by filtration and washed with water to remove any impurities. The microcapsules were dried using lyophilisa-tion to obtain free flow powder. 

figure 2: Retinol stability in gel formulation incubated at 40°C for four weeks. CelluCap R (grey bar) compared to free retinol (blue bar). Data is represented as mean retinol content (percentage of initial).
figure 2: Retinol stability in gel formulation incubated at 40°C for four weeks. CelluCap R (grey bar) compared to free retinol (blue bar). Data is represented as mean retinol content (percentage of initial).

Microcapsules characterisation

Retinol was quantified by reverse-phase HPLC using a Jasco HPLC system equipped with variable ultraviolet detector. Separations were carried out using Ace 3, C18-PFP column (150 × 4.6 mm), with isocratic mobile phase containing 85%v/v methanol and 15%v/v water, at a flowrate of 1.0 ml/min. Retinol was detected at 325 nm. The following parameters were evalu-ated: Content (percentage of concentration of retinol in the microcapsules) and en-trapment efficiency (percentage of estimat-ed content / theoretical content).

Microcapsules were analysed for its size and size distribution using laser diffraction particle size distribution analyser Horiba LA-350.

Studies and tests

The stability of the microcapsules was evaluated and compared to free retinol. The encapsulated and free retinol were incorpo-rated in a water gel base formulation (pH 7.3) and incubated at 40°C in closed glass vessels protected from light. Its stability was evaluated by measuring retinol content (percentage of initial) by HPLC method after two and four weeks storage.

In-vivo efficacy test: A clinical study was performed to evaluate the anti-ageing activity of the microcapsules. Twenty sub-jects applied base night cream containing 1.2% (equivalent to 0.1% of free retinol) twice daily for four weeks. 

The efficacy of the treatment was evaluat-ed via the Visa CR imaging system. Images were analysed by ImagePro software to determine changes in the appearance of facial skin texture7,8.

At baseline and after four weeks of use, a trained technician took Cutometer meas-urements of each subject to measure the skin's firmness.

Antioxidant activity: The antioxidant activity compared to free Retinol was determined using 2,2-Diphenyl-1- picrylhy-drazyl (DPPH) method. The reduction of DPPH was measured by spectrophotometer9.

figure 3: representative image of reduction of the appearance of forehead wrinkles at (left) Baseline and 28 days treatment with CelluCap R (right).
figure 3: representative image of reduction of the appearance of forehead wrinkles at (left) Baseline and 28 days treatment with CelluCap R (right).

Results

Microcapsules characterisation: The obtained free flowing powder of microcap-sules had an average retinol content of 8.6± 0.5 percent with mean entrapment efficacy of 90.1± 1.7 percent.

The mean size values of the microcapsules were about 14µm. The presence of one narrow peak indicates that the microcap-sules population is homogenous in size (figure 1).

The stability of encapsulated retinol com-pared to free retinol, both incorporated into a topical base gel formulation (pH 7.3), was evaluated over four weeks at 40°C.

The relative content of retinol (percentage of initial) in each sample (free retinol com-pared to encapsulate retinol) were meas-ured as shown in figure 2.

The results show that the mean relative retinol content after four weeks at 40°C was significantly higher while formulating with the microcapsules compared to free retinol. 

figure 4: representative image of visible softening of marionette lines at baseline (left) and 28 days treatment with CelluCap R (right).
figure 4: representative image of visible softening of marionette lines at baseline (left) and 28 days treatment with CelluCap R (right).

In addition, 90% of participants agreed that the appearance of their fine lines and wrin-kles were reduced and a full 100% agreed their skin felt firmer and looked younger, healthier, clearer, softer, smoother, and more even. 

The antioxidant activity of the micro-capsules compared to free retinol was eval-uated by DPPH assay by determining the percentage inhibition of DPPH radicals. After the encapsulation of retinol by en-capsulation technology, its ability to "scav-enge" DPPH radicals was significantly increased as shown in figure 5.

figure 5: Antioxidant activity of CelluCap R microcapsules compared to free retinol (the final concentration of retinol in both tested samples was equal).
figure 5: Antioxidant activity of CelluCap R microcapsules compared to free retinol (the final concentration of retinol in both tested samples was equal).

Conclusions

Retinol is one of the most popular ingredi-ents in skincare. However, there are certain problems and challenges that scientists face when incorporating this sensitive ingredient into skincare formulations; namely, the challenge of maintaining its stability and potency over time.

But it was possible to develop a stable form of encapsulated retinol, to ensure its efficient delivery while preserving its potency and efficacy.

These microcapsules were designed to release the retinol following mechanical pressure, which results in breakage of the polymeric shell. Upon application, while rubbing the formulation into skin, the pol-ymeric shell collapses and the microcap-sules begin to fracture, releasing the encap-sulated retinol. Microcapsules breakdown into invisible particles, but still retain a portion of the payload to continue and deliver over time.

The results of this study clearly show that retinol microcapsules are significantly more stable than the freeform of retinol. In addition, the in-vivo clinical study clear-ly shows that the encapsulation process preserves the dermatological activity of retinol as an anti-ageing/wrinkle agent with fast-acting results. 

References

1 Pandel R., Poljšak B., Godic A, Dahmane R. (2013) Skin Photo-aging and the Role of Antioxi-dants in Its Prevention. ISRN Dermatology. 12, eCollection 2013
2 Poljsak B., Dahmane R., Godic A. (2013) Skin and antioxidants.  Journal of Cosmetic and Laser Therapy. 15, 107-113
3 Chen L, Hu JY, Wang SQ. (2012) The role of antioxidants in photoprotection: a critical review. Journal of the American Academy of Dermatolo-gy. 67, 1013–1024
4 Žane Temova Rakuša et al. Retinoid stability and degradation kinetics in commercial cosmetic products. J Cosmet Dermatol. 2021. Jul; 20(7):2350-2358.
5 Jelvehgari M, Montazam SH. (2012) Compari-son of microencapsulation by emulsion-solvent extraction/evaporation technique using derivatives cellulose and acrylate-methacrylate copolymer as carriers. Jundishapur journal of natural pharma-ceutical products. 7,144-152.
6 Freitas S, Merkle HP, Gander B.(2005) Micro-encapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. Journal of con-trolled release.102, 313-332
7 Corinne Granger et al. Prospective Evaluation of the Efficacy of a Food Supplement in Increas-ing Photoprotection and Improving Selective Markers Related to Skin Photo-Ageing. Dermatol Ther. 2020. Feb;10(1):163-178
8 Jong-Seong Ryu et al. Improving lip wrinkles: lipstick-related image analysis. Skin Res Technol.  2005 Aug;11(3):157-64
9 Formagio AS, et al.2014. Evaluation of Antiox-idant Activity, Total Flavonoids, Tannins and Phe-nolic Compounds in Psychotria Leaf Extracts. Antioxidants (Basel, Switzerland).  10: 745-757.

Dr Saher Duchi,
Chief Scientist,
Tagra Biotechno­logies,
Israel,
www.tagra.com 

Dr Danny Goldstein,
VP R&D,
Tagra Biotechnologies,
Israel,
www.tagra.com 

More about:

Advertisement

News Ingredients

Advertisement